Other Substantial Matters proposed by Member States • Challenges to the identification of new illicit drugs: Discussion on strategies and approaches by laboratories to enhance the capacity of forensic personnel and harnessing technology to improve identification methods • Harm reduction measures • Drug Policy: social determinants, disproportionate impacts, and barriers to service access • Current …
CND Intersessional – Session 5 – Legal, Scientific, and Regulatory Challenges in Scheduling Substances
Chair: Good Morning. Secretariat: (organizational matters + scheduling 101) Moderator/intro: Mr. Justice Tettey, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC: Good morning, dear colleagues. Thank you for this opportunity to address the question you posed about our scheduling system. First, I’d like to say that I couldn’t agree more with the previous speaker regarding the …
CND Intersessional – Session 4 – Illicit Trafficking in Substances and Precursors, and Domestic Diversion of Precursor Chemicals
Chair: Hello, good afternoon, everyone. Welcome back. Let’s begin the afternoon session. Introductory remarks: Mr. Michael Osman, Social Affairs Officer, Border Management Branch, UNODC: I’ll provide a brief overview to leave more time for our interactive discussions with the panel and delegates. This morning, we discussed the rising drug supply, a pressing issue for the …
CND Intersessional – Session 3 – Challenges in Illicit Cultivation and Production of Narcotic Drugs and Psychotropic Substances
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: (Welcome) Secretariat: (organizational matters) Moderator/ intro, Ms. Anja Korenblik, Chief, Geospatial Analysis and Programme Delivery Section, RAB, UNODC: Good morning, everyone. We’ll begin this session on the challenges in the cultivation and production of narcotic drugs and psychoactive substances …
CND Intersessional – Session 2 – Synthetic Opioids and Non-medical Use of Prescription Drugs
2024 Thematic Discussions on the Implementation of All International Drug Policy Commitments, Following-up to the 2019 Ministerial Declaration Chair: Welcome back. Ms. Asma Fakhri, UNODC, on behalf of Mr. Justice TETTEY, Chief, Drugs, Laboratory and Scientific Services Branch, UNODC (Moderator): Thank you all for gathering to address the growing challenges posed by synthetic opioids and the non-medical …
CND Intersessional – Session 1 – Expanding range of drugs and synthetic opioids and nonmedical use of prescription drugs
CND Intersessional meeting – Thematic discussions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Secretariat: (administrative and organizational issues) Chair: Welcome. The topics of the three days of this meeting are identified in the 2019 declaration. One of the challenges is the funding and diversification of drug …